HealthTech BioActives (HTBA) has announced its attendance to this year's CPHI Worldwide.
The polyphenol and vitamin B12 specialist will present its range of patient-centric health solutions, while also talking visitors through its expertise in the manufacture and commercialisation of natural flavonoids and active B12 forms.
HTBA's product portfolio currently centres around its citrus flavonoids, but the company will be exploring the use of vegetal sources to improve health.
This follows HTBA's partnership with Abolis Biotechnologies, who aim to advance the use of naturally-derived active pharmaceutical ingredients (APIs) such as polyphenols in the industry.
HealthTech BioActives' Pharma Division Director, Álvaro Nocete, commented: "CPHI Milan presents the perfect platform for us to cultivate new partnerships while continuing to deliver science-backed ingredients that harness the power of nature to promote health and wellbeing,”
“With more than 40 years’ experience as an API manufacturer, we’re excited to explore opportunities to expand beyond citrus flavonoids by tapping into new vegetal sources."
"We also want to broaden the scientific foundation of our ingredients, while continuing to develop processing technologies that promote sustainable manufacturing.”
To start a conversation or find out more about HTBA’s established premium-quality portfolio, including diosmin, hesperidin and methylcobalamin, visit booth #2B74.